Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Mint Reports Sudarshan Pharma Industries Limited Shares Fell to ₹34.65
Sudarshan Pharma Industries Limited's September-quarter filing showed growth in standalone revenue and profit, while Mint reported an Oct. 30 share decline that put analysts' price levels in focus. The company's board approved unaudited standalone…
A pharma giant is moving past one patent cliff - but another is already looming
Novartis CEO Vas Narasimhan told CNBC on Tuesday that its drug remibrutinib could become 'one of our largest medicines in history.' But analysts slashed the peak sales forecast for the drug after a late-stage clinical trial for patients with…
BridgeBio Pharma: Q3 Earnings Snapshot
PALO ALTO, Calif. (AP) — PALO ALTO, Calif. (AP) — BridgeBio Pharma Inc. (BBIO) on Thursday reported a loss of $56.7 million in its third quarter. The Palo Alto, California-based company said it had a loss of 42 cents per share. The…
Pharma companies continue to pay millions to doctors
In 2025, these payments – in the form of conference attendance fees, accommodation expenses, fees and consultancy fees – totalled CHF234 million ($283 million). This figure is CHF28 million lower than in 2024, but the decline is…
The Economic Times Reports Sun Pharma Above Its 20-day Average
The Economic Times reported Sun Pharmaceutical Industries Limited (Sun Pharma) shares above a reported 20-day simple moving average in early trading Oct. 30, the date set for a board meeting to consider and approve results. In its 11:46:26 p.m. ET…
West Pharma earnings show it's more than a GLP-1 play. Why we see more upside
West Pharmaceutical Services once again showed that it's more than just a GLP-1 play. Since CNBC highlighted the stock's attractive valuation in August, shares have gained around 20%. On Thursday, the stock hit a 52-week high in the wake of a…
Sun Pharma's profit falls on Organon deal charge; specialty drug sales remain strong
Oct 30 (Reuters) – India's Sun Pharmaceutical Industries reported a drop in second-quarter profit on Friday, as a one-time charge largely tied to its planned acquisition of Organon weighed, though demand for specialty…
Should You Buy Royalty Pharma Stock Before Nov. 4?
Royalty Pharma (RPRX +1.64%) will report Q3 2026 earnings pre-market on Nov. 4. After pulling back in September due to a major setback with one of its drug candidates, the pharmaceutical royalty holding company's shares have been soaring back…
Embattled Purdue Pharma exec ordered to stop blocking sale of mansion to fund opioid settlements
Former Purdue Pharma chairman Richard Sackler was ordered stop interfering with the sale of his sprawling Connecticut mansion — as the Sackler family's $7.4 billion opioid settlement threatens to cost him one of his luxury homes. A federal…
India orders Sun Pharma to halt eye-care drug production at plant after quality lapses
HYDERABAD, India – Indian drug regulators ordered Sun Pharmaceutical Industries to stop manufacturing, selling and distributing ophthalmic products made at its Assam facility after finding failure in its quality management system, documents…
Pharma H1 exports up 5% to $16.14-bn. as Europe offsets U.S. slowdown
India's pharmaceutical exports rose 4.90% year-on-year (YoY) to $16.14 billion in the first half of FY27, as strong demand from Europe, Latin America and ASEAN markets offset a decline in shipments to North America, including the crucial U.S.
Nifty reclaims 23,000 to end October on a positive note; IT and Pharma lead, midcaps bleed
Within the Nifty 500 universe, only 108 stocks advanced, and both the Nifty Midcap 100 and Nifty Smallcap 100 ended in the red, falling 0.93 per cent and 1.85 per cent respectively. India VIX climbed around 3 per cent to 15.6. IT, healthcare and…
Stock market today: Sensex, Nifty extend gains for second day as IT, pharma stocks lead rally
Indian equity benchmarks closed in positive territory for the second straight session on Friday, driven by buying in IT and pharma counters, while broader markets remained under pressure. The Sensex advanced 308.49 points, or 0.42 per cent, to…
Swiss Solidarity raises CHF5 million for Sudan war victims
The mid-terms and democracy, a new national park, and political hamburgers Read more: The mid-terms and democracy, a new national park, and political hamburgers Switzerland, China and Germany's mistakes Read more: Switzerland, China and Germany's…
Royalty Pharma PLC $RPRX Stock Acquired by Asset Management One Co. Ltd.
Asset Management One Co. Ltd. lifted its holdings in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 15.7% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned…
Receive a Daily briefing on Pharma Industry News
Get Started